A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new Alzheimer's disease treatments: Intranasal insulin, delivered via a simple nasal ...
Stocktwits on MSN
Alaunos reports positive preclinical obesity drug results across weight, liver, insulin markers
Researchers observed treatment-linked improvements in body composition, including lower fat mass and relatively higher lean ...
Rezolute, Inc. RZLT reported an interim update from its ongoing Phase 3 upLIFT study evaluating ersodetug in patients with ...
In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This approach could change how type 1 diabetes is treated, moving beyond just ...
Retatrutide altered circulating metabolites and lipids linked to fatty acid oxidation and insulin resistance in people with ...
Oramed Pharmaceuticals is downgraded to Hold due to the failed phase 3 trial for ORMD-0801 in Type 2 Diabetes. Read more on ...
Explore the potential benefits and risks of using type 2 diabetes drugs like Ozempic and metformin off-label to manage weight ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results